|
Market Closed -
London S.E.
11:35:13 2026-10-02 EDT
|
5-day change | 1st Jan Change | ||
| 1.125 GBX | 0.00% |
|
+18.42% | -40.79% |
| 09-24 | Stocks mixed as bond sell-off spreads | AN |
| 09-24 | WINNERS & LOSERS: Quantum Data restored; Asos upbeat on outlook | AN |
| Market Cap | 2.16M 2.86M 2.54M 2.37M 4.07M 275M 4.11M 28.7M 11.13M 140M 10.72M 10.5M 451M | P/E 2024 |
-2.47x | P/E 2025 | -3.56x |
|---|---|---|---|---|---|
| Enterprise Value | 2.01M 2.66M 2.36M 2.2M 3.79M 256M 3.83M 26.71M 10.36M 131M 9.98M 9.77M 420M | EV / Sales 2024 |
61,809,222x | EV / Sales 2025 | 76,138,323x |
| Free-Float |
81.3% | Yield 2024 * |
-
| Yield 2025 | - |
| 02-06 | BSF : Proxy Form | PU |
| 02-06 | BSF : Notice of AGM | PU |
| 25-03-06 | BSF : Publication of Prospectus | PU |
| 25-03-06 | BSF : Prospectus | PU |
| 25-02-07 | BSF : Proxy Form | PU |
| 1 week | +18.42% | ||
| 1 month | +2.27% | ||
| 3 months | +25.28% | ||
| 6 months | -47.06% | ||
| Current year | -40.79% |
| 1 week | 0.91 | 1.25 | |
| 1 month | 0.9 | 1.25 | |
| Current year | 0.5 | 4 | |
| 1 year | 0.5 | 4 | |
| 3 years | 0.5 | 12.45 | |
| 5 years | 0.5 | 23.88 | |
| 10 years | 0.5 | 23.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
Che Connon
CEO | Chief Executive Officer | 54 | - |
Graham Duncan
DFI | Director of Finance/CFO | 62 | 2022-06-05 |
Ricardo Gouveia
PRN | Corporate Officer/Principal | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Geoffrey Baker
CHM | Chairman | 70 | 2025-12-04 |
Kian Jing Ow
BRD | Director/Board Member | 60 | 2021-08-04 |
Che Connon
BRD | Director/Board Member | 54 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 6/18/24 | Buy | Chief Financial Officer | 500 | 0.0005% | ||
| 6/18/24 | Buy | Chief Financial Officer | 11,798 | 0.0114% | ||
| 6/18/24 | Buy | Chief Financial Officer | 23,500 | 0.0227% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | +18.42% | -62.50% | -88.75% | 2.86M | ||
| -0.61% | -3.43% | +39.40% | +112.31% | 1,019B | ||
| -1.02% | -5.60% | +37.67% | +65.02% | 617B | ||
| +1.11% | -0.58% | +11.10% | +77.28% | 464B | ||
| +0.34% | -3.01% | +61.21% | +40.71% | 356B | ||
| -0.95% | -4.05% | +21.60% | +39.37% | 333B | ||
| -1.46% | -2.89% | +11.84% | +24.60% | 267B | ||
| -1.35% | -5.43% | -4.69% | +8.40% | 244B | ||
| -1.04% | -2.79% | +35.52% | +51.34% | 218B | ||
| -1.87% | -4.10% | +30.92% | +95.33% | 179B | ||
| Average | -0.68% | -1.21% | +18.21% | +42.56% | 369.72B | |
| Weighted average by Cap. | -0.60% | -3.33% | +30.52% | +68.96% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 0.06 0.08 0.07 0.06 0.11 7.37 0.11 0.77 0.3 3.76 0.29 0.28 12.09 | 0.05 0.07 0.06 0.06 0.1 6.74 0.1 0.7 0.27 3.44 0.26 0.26 11.05 |
| Net income | -1.67M -2.21M -1.97M -1.83M -3.16M -213M -3.18M -22.23M -8.62M -109M -8.31M -8.13M -350M | -1.11M -1.47M -1.31M -1.22M -2.1M -142M -2.12M -14.81M -5.74M -72.42M -5.53M -5.42M -233M |
| Net Debt | -560K -741K -658K -614K -1.06M -71.36M -1.07M -7.44M -2.89M -36.39M -2.78M -2.72M -117M | -149K -197K -175K -163K -281K -19M -284K -1.98M -768K -9.69M -740K -725K -31.16M |
Employees
14
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-02 | GBX 1.125 | 0.00% | 953,314 |
| 26-10-01 | GBX 1.125 | 0.00% | 5,806,071 |
| 26-09-30 | GBX 1.125 | 0.00% | 6,015,048 |
| 26-09-29 | GBX 1.125 | +7.66% | 1,176,318 |
| 26-09-28 | GBX 1.045 | +10.00% | 1,304,581 |
- Stock Market
- Stocks
- BSFA Stock
Select your edition
All financial news and data tailored to specific country editions
















